{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T02:43:05Z","timestamp":1778294585596,"version":"3.51.4"},"reference-count":171,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010803","name":"Government of West Bengal Department of Science and Technology and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/INF\/22\/SP45382\/2022"],"award-info":[{"award-number":["BT\/INF\/22\/SP45382\/2022"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR47726\/CMD\/150\/26\/2023"],"award-info":[{"award-number":["BT\/PR47726\/CMD\/150\/26\/2023"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR38493\/TRM\/120\/465\/2020"],"award-info":[{"award-number":["BT\/PR38493\/TRM\/120\/465\/2020"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/FST\/LSII-046\/2016"],"award-info":[{"award-number":["SR\/FST\/LSII-046\/2016"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017896","name":"Jawaharlal Nehru University","doi-asserted-by":"publisher","award":["09\/263(1172)2019-EMR-I"],"award-info":[{"award-number":["09\/263(1172)2019-EMR-I"]}],"id":[{"id":"10.13039\/100017896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.pnpbp.2025.111403","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:03:46Z","timestamp":1747739026000},"page":"111403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Understanding borderline personality disorder: Clinical features, neurobiological insights, and therapeutic strategies"],"prefix":"10.1016","volume":"139","author":[{"given":"Surendar","family":"Ellappan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhea","family":"Subba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal Chandra","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pnpbp.2025.111403_bb0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1521\/pedi_2019_33_445","article-title":"Off-label use of second-generation antipsychotics in borderline personality disorder: a survey of Italian psychiatrists","volume":"35","author":"Aguglia","year":"2021","journal-title":"J. Personal. Disord."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111403_bb0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/PRA.0000000000000813","article-title":"The role of hopelessness in patients with borderline personality disorder","volume":"30","author":"Aguglia","year":"2024","journal-title":"J. Psychiatr. Pract."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111403_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/21677026211056686","article-title":"Negative affectivity and disinhibition as moderators of an interpersonal pathway to suicidal behavior in borderline personality disorder","volume":"10","author":"Allen","year":"2022","journal-title":"Clin. Psychol. Sci."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neubiorev.2014.01.003","article-title":"Genetics of borderline personality disorder: systematic review and proposal of an integrative model","volume":"40","author":"Amad","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0025","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2022"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12991-023-00449-y","article-title":"Alternation in functional connectivity within default mode network after psychodynamic psychotherapy in borderline personality disorder","volume":"22","author":"Amiri","year":"2023","journal-title":"Ann. General Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111403_bb0035","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/eip.12461","article-title":"Relationships between the frequency and severity of non-suicidal self-injury and suicide attempts in youth with borderline personality disorder","volume":"13","author":"Andrewes","year":"2019","journal-title":"Early Interv. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamapsychiatry.2022.0010","article-title":"Effectiveness of predominantly group Schema therapy and combined individual and group Schema therapy for borderline personality disorder: a randomized clinical trial","volume":"79","author":"Arntz","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111403_bb0045","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1017\/S0033291722003634","article-title":"Dropout from psychological treatment for borderline personality disorder: a multilevel survival meta-analysis","volume":"53","author":"Arntz","year":"2023","journal-title":"Psychol. Med."},{"issue":"3\u20134","key":"10.1016\/j.pnpbp.2025.111403_bb0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000507589","article-title":"International assessment of DSM-5 and ICD-11 personality disorder traits: toward a common nosology in DSM-5.1","volume":"53","author":"Bach","year":"2020","journal-title":"Psychopathology"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0055","article-title":"A person-centered perspective on the combined DSM-5 AMPD\/ICD-11 personality model: utility, relationship with the categorical personality disorder model, and capacity to differentiate between levels of identity functioning","volume":"13","author":"Bastiaens","year":"2022","journal-title":"Front. Psychol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0060","article-title":"A randomized controlled trial of a Mentalization-based intervention (MBT-FACTS) for families of people with borderline personality disorder","volume":"10","author":"Bateman","year":"2019","journal-title":"Personal. Disord. Theory Res. Treat."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111403_bb0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/0269881108095715","article-title":"Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study","volume":"24","author":"Bellino","year":"2010","journal-title":"J. Psychopharmacol."},{"issue":"10310","key":"10.1016\/j.pnpbp.2025.111403_bb0070","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/S0140-6736(21)00476-1","article-title":"Borderline personality disorder","volume":"398","author":"Bohus","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111403_bb0075","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s40263-017-0458-4","article-title":"Efficacy and tolerability of Asenapine compared with olanzapine in borderline personality disorder: an open-label randomized controlled trial","volume":"31","author":"Bozzatello","year":"2017","journal-title":"CNS Drugs"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111403_bb0080","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1469-7610.2004.00401.x","article-title":"The borderline personality diagnosis in adolescents: gender differences and subtypes","volume":"46","author":"Bradley","year":"2005","journal-title":"J. Child Psychol. Psychiatry Allied Discip."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/inm.13413","article-title":"Exploring the pathways to diagnosis for men with borderline personality disorder: a qualitative study","volume":"34","author":"Broadbear","year":"2025","journal-title":"Int. J. Ment. Health Nurs."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065584","article-title":"Increased prefrontal cortical thickness is associated with enhanced abilities to regulate emotions in PTSD-free women with borderline personality disorder","volume":"8","author":"Bruehl","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1590\/1516-4446-2019-0591","article-title":"Improvement in borderline personality disorder symptomatology after repetitive transcranial magnetic stimulation of the dorsomedial prefrontal cortex: preliminary results","volume":"43","author":"Calder\u00f3n-Moctezuma","year":"2021","journal-title":"Brazili. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jad.2022.04.050","article-title":"Effects of pharmacological treatments on neuroimaging findings in borderline personality disorder: a review of FDG-PET and fNIRS studies","volume":"308","author":"Cattarinussi","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40479-021-00147-9","article-title":"Heterogeneity of borderline personality disorder symptoms in help-seeking adolescents","volume":"8","author":"Cavelti","year":"2021","journal-title":"Borderline Personal. Disord. Emot. Dysregul."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0110","series-title":"StatPearls","article-title":"Borderline personality disorder","author":"Chapman","year":"2024"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0115","doi-asserted-by":"crossref","DOI":"10.1177\/10398562211065296","article-title":"Disjunction in the subjective and objective measurement of co-occurring depression in borderline personality disorder \u2013 implications for diagnosis","volume":"30","author":"Cheney","year":"2022","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0120","series-title":"StatPearls","article-title":"Antipsychotic medications","author":"Chokhawala","year":"2025"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0125","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/erv.747","article-title":"Cognitive\u2013emotional\u2013Behavioural therapy for the eating disorders: working with beliefs about emotions","volume":"14","author":"Corstorphine","year":"2006","journal-title":"Eur. Eat. Disord. Rev."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111403_bb0130","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1176\/appi.ajp.2018.17091006","article-title":"The clinical effectiveness and cost-effectiveness of lamotrigine in borderline personality disorder: a randomized placebo-controlled trial","volume":"175","author":"Crawford","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111403_bb0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1037\/ccp0000833","article-title":"Psychotherapies for the treatment of borderline personality disorder: a systematic review","volume":"92","author":"Crotty","year":"2024","journal-title":"J. Consult. Clin. Psychol."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111403_bb0140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1039856214566830","article-title":"Mentalization-based therapy (MBT): an overview","volume":"23","author":"Daubney","year":"2015","journal-title":"Australas. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111403_bb0145","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/jclp.23725","article-title":"Randomized effectiveness-implementation trial of dialectical behavior therapy interventions for young people with borderline personality disorder symptoms","volume":"80","author":"de Andrade","year":"2024","journal-title":"J. Clin. Psychol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0150","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2021.2231","article-title":"An fMRI study of cognitive reappraisal in major depressive disorder and borderline personality disorder","volume":"64","author":"De la Pe\u00f1a-Arteaga","year":"2021","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0155","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3389\/fnhum.2016.00582","article-title":"Repetitive TMS on left cerebellum affects impulsivity in borderline personality disorder: a pilot study","volume":"10","author":"De Vidovich","year":"2016","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0160","article-title":"Effects of BPD tendencies and subjective well-being on NSSI in adolescents with PTSD","volume":"14","author":"Deng","year":"2023","journal-title":"Front. Psychol."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111403_bb0165","first-page":"819","article-title":"Training in cognitive reappraisal normalizes whole-brain indices of emotion regulation in borderline personality disorder","volume":"9","author":"Denny","year":"2024","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111403_bb0170","doi-asserted-by":"crossref","DOI":"10.2196\/13479","article-title":"Development of an ambulatory biofeedback app to enhance emotional awareness in patients with borderline personality disorder: multicycle usability testing study","volume":"7","author":"Derks","year":"2019","journal-title":"JMIR Mhealth Uhealth"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0175","series-title":"Metacognitive Interpersonal Therapy for Personality Disorders","author":"Dimaggio","year":"2015"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111403_bb0180","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1017\/S0033291707002024","article-title":"Heritability of borderline personality disorder features is similar across three countries","volume":"38","author":"Distel","year":"2008","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.copsyc.2017.09.001","article-title":"Personality disorders: community prevalence and socio-demographic correlates","volume":"21","author":"Eaton","year":"2018","journal-title":"Curr. Opin. Psychol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bjc.12123","article-title":"Exploring the effectiveness of combined mentalization-based group therapy and dialectical behaviour therapy for inpatients with borderline personality disorder \u2013 a pilot study","volume":"56","author":"Edel","year":"2017","journal-title":"Br. J. Clin. Psychol."},{"issue":"Suppl A","key":"10.1016\/j.pnpbp.2025.111403_bb0195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1521\/pedi_2021_35_513","article-title":"Alexithymia, affective lability, impulsivity, and childhood adversity in borderline personality disorder","volume":"35","author":"Edwards","year":"2021","journal-title":"J. Personal. Disord."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0200","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.psc.2018.07.008","article-title":"Community and clinical epidemiology of borderline personality disorder","volume":"41","author":"Ellison","year":"2018","journal-title":"Psychiatr. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111403_bb0205","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/npp.2015.153","article-title":"Impulsivity and aggression in female BPD and ADHD patients: association with ACC glutamate and GABA concentrations","volume":"41","author":"Ende","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111403_bb0210","article-title":"Recurrent depression and borderline personality disorder in a patient with Ehlers-Danlos syndrome","volume":"10","author":"Espiridion","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0215","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jad.2021.12.038","article-title":"Dorsomedial prefrontal rTMS for depression in borderline personality disorder: a pilot randomized crossover trial","volume":"301","author":"Feffer","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19010079","article-title":"\u201cFamily connections\u201d, a DBT-based program for relatives of people with borderline personality disorder during the COVID-19 pandemic: a focus group study","volume":"19","author":"Fern\u00e1ndez-Felipe","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111403_bb0225","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/brainsci13071001","article-title":"One year of outpatient dialectical behavioral therapy and its impact on neuronal correlates of attachment representation in patients with borderline personality disorder using a personalized fMRI task","volume":"13","author":"Flechsig","year":"2023","journal-title":"Brain Sci."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111403_bb0230","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/medicina60020283","article-title":"Brexpiprazole attenuates aggression, suicidality and substance use in borderline personality disorder: a case series","volume":"60","author":"Francis","year":"2024","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0235","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40479-021-00146-w","article-title":"Latent profiles of patients with borderline pathology based on the alternative DSM-5 model for personality disorders","volume":"8","author":"Gamache","year":"2021","journal-title":"Borderline Personal. Disord. Emot. Dysregul."},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111403_bb0240","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40263-021-00855-4","article-title":"Pharmacological treatments for borderline personality disorder: a systematic review and Meta-analysis","volume":"35","author":"Gartlehner","year":"2021","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0245","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jpsychires.2014.06.020","article-title":"Dialectical behavior therapy alters emotion regulation and amygdala activity in patients with borderline personality disorder","volume":"57","author":"Goodman","year":"2014","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111403_bb0250","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1521\/pedi.2021.35.5.776","article-title":"High prevalence of borderline personality disorder among psychiatric inpatients admitted for suicidality","volume":"35","author":"Gregory","year":"2021","journal-title":"J. Personal. Disord."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111403_bb0255","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.pnpbp.2009.08.022","article-title":"Neural correlates of impaired emotional discrimination in borderline personality disorder: an fMRI study","volume":"33","author":"Guitart-Masip","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0260","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/YCT.0000000000000857","article-title":"Nonremission after electroconvulsive therapy in individuals with major depression: role of borderline personality disorder","volume":"38","author":"Hein","year":"2022","journal-title":"J. ECT"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111403_bb0265","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archgenpsychiatry.2010.93","article-title":"Correlation of glutamate levels in the anterior cingulate cortex with self-reported impulsivity in patients with borderline personality disorder and healthy controls","volume":"67","author":"Hoerst","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111403_bb0270","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/pmh.1231","article-title":"A biofeedback intervention to control impulsiveness in a severely personality disordered forensic patient","volume":"7","author":"Howard","year":"2013","journal-title":"Personal. Ment. Health"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10802-011-9555-x","article-title":"A developmental neuroscience of borderline pathology: emotion dysregulation and social baseline theory","volume":"40","author":"Hughes","year":"2012","journal-title":"J. Abnorm. Child Psychol."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111403_bb0280","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1037\/per0000605","article-title":"Effective therapeutic components in systems training for emotional predictability and problem solving (STEPPS) for borderline personality disorder","volume":"14","author":"Isaia","year":"2023","journal-title":"Personal. Disord. Theory Res. Treat."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.772081","article-title":"Neural changes in borderline personality disorder after dialectical behavior therapy\u2013a review","volume":"12","author":"Iskric","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1176\/appi.focus.20220070","article-title":"Biofeedback and treatment for borderline personality disorder","volume":"21","author":"Jacob","year":"2023","journal-title":"Focus"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2024.152478","article-title":"The course of borderline personality disorder from adolescence to early adulthood: a 5-year follow-up study","volume":"132","author":"J\u00f8rgensen","year":"2024","journal-title":"Compr. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0300","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S0033291706007288","article-title":"A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients","volume":"36","author":"Joyce","year":"2006","journal-title":"Psychol. Med."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111403_bb0305","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.biopsych.2009.03.005","article-title":"Relationships between angry-impulsive personality traits and genetic polymorphisms of the dopamine transporter","volume":"66","author":"Joyce","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0310","first-page":"313","article-title":"The presence of both serotonin 1A receptor (HTR1A) and dopamine transporter (DAT1) gene variants increase the risk of borderline personality disorder","volume":"4","author":"Joyce","year":"2013","journal-title":"Front. Genet."},{"issue":"15","key":"10.1016\/j.pnpbp.2025.111403_bb0315","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1017\/S0033291724002034","article-title":"Diagnostic profiles among suicide decedents with and without borderline personality disorder","volume":"54","author":"Kaufman","year":"2024","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0320","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jad.2023.02.034","article-title":"Suicidal urges and attempted suicide at multiple time scales in borderline personality disorder","volume":"329","author":"Kaurin","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0325","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1037\/ccp0000760","article-title":"Reflective functioning and its potential to moderate the efficacy of manualized psychodynamic therapies versus other treatments for borderline personality disorder","volume":"91","author":"Keefe","year":"2022","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0330","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pnpbp.2015.07.002","article-title":"Resting state vagal tone in borderline personality disorder: a meta-analysis","volume":"64","author":"Koenig","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0335","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brat.2014.07.001","article-title":"Reasons for premature termination of dialectical behavior therapy for inpatients with borderline personality disorder","volume":"60","author":"Kr\u00f6ger","year":"2014","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0340","article-title":"Effects of intermittent theta burst stimulation add-on to dialectical behavioral therapy in borderline personality disorder: results of a randomized, sham-controlled pilot trial","author":"Kujovic","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0345","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/YCT.0000000000000533","article-title":"Effectiveness of electroconvulsive therapy in patients with major depressive disorder and comorbid borderline personality disorder","volume":"35","author":"Lee","year":"2019","journal-title":"J. ECT"},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111403_bb0350","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jama.2023.0589","article-title":"Borderline personality disorder","volume":"329","author":"Leichsenring","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2025.111403_bib847","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3389\/fnins.2019.00971","article-title":"Structural and Functional Connectivity of the Anterior Cingulate Cortex in Patients With Borderline Personality Disorder","volume":"13","author":"Lei","year":"2019","journal-title":"Front Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0355","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/wps.21156","article-title":"Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies","volume":"23","author":"Leichsenring","year":"2024","journal-title":"World Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0360","doi-asserted-by":"crossref","first-page":"E431","DOI":"10.1503\/jpn.230085","article-title":"Altered amygdalar emotion space in borderline personality disorder normalizes following dialectical behaviour therapy","volume":"48","author":"Levine","year":"2023","journal-title":"J. Psychiatry Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bib846","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.108.062984","article-title":"Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials","volume":"196","author":"Lieb","year":"2010","journal-title":"Br J Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0365","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/acps.13564","article-title":"Association of pharmacological treatments and real-world outcomes in borderline personality disorder","volume":"147","author":"Lieslehto","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0370","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.17130","article-title":"Comparative effectiveness of pharmacotherapies for the risk of attempted or completed suicide among persons with borderline personality disorder","volume":"6","author":"Lieslehto","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111403_bb0375","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/jamapsychiatry.2014.3039","article-title":"Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis","volume":"72","author":"Linehan","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111403_bb0380","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1139\/jpn.0716","article-title":"Neuroimaging and genetics of borderline personality disorder: a review","volume":"32","author":"Lis","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0385","doi-asserted-by":"crossref","DOI":"10.1111\/pcn.13792","article-title":"Reduction of rejection-related emotions by transcranial direct current stimulation over right ventrolateral prefrontal cortex in borderline personality disorder: a double-blind randomized pilot study","author":"Lisco","year":"2025","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113261","article-title":"Change in core symptoms of borderline personality disorder by tDCS: a pilot study","volume":"291","author":"Lisoni","year":"2020","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111403_bb0395","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.neuroscience.2003.12.009","article-title":"Repeated exposure to social stress has long-term effects on indirect markers of dopaminergic activity in brain regions associated with motivated behavior","volume":"124","author":"Lucas","year":"2004","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111403_bb0400","article-title":"From child abuse to developing borderline personality disorder into adulthood: exploring the neuromorphological and epigenetic pathway","volume":"12","author":"Mainali","year":"2020","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111403_bb0405","doi-asserted-by":"crossref","first-page":"229","DOI":"10.31887\/DCNS.2020.22.3\/rmaldonado","article-title":"The endocannabinoid system in modulating fear, anxiety, and stress","volume":"22","author":"Maldonado","year":"2020","journal-title":"Dialogues Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111403_bb0410","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1503\/jpn.170132","article-title":"Assessing the marks of change: how psychotherapy alters the brain structure in women with borderline personality disorder","volume":"43","author":"Mancke","year":"2018","journal-title":"J. Psychiatry Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111403_bb0415","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/YIC.0000000000000004","article-title":"Asenapine in the treatment of borderline personality disorder: an atypical antipsychotic alternative","volume":"29","author":"Mart\u00edn-Blanco","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111403_bb0420","first-page":"143","article-title":"Methodological note: neurofeedback: a comprehensive review on system design, methodology and clinical applications","volume":"7","author":"Marzbani","year":"2016","journal-title":"Basic Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0425","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000525102","article-title":"The effectiveness of 6 versus 12 months of dialectical behavior therapy for borderline personality disorder: a noninferiority randomized clinical trial","volume":"91","author":"McMain","year":"2022","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0430","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jad.2024.08.041","article-title":"Prefrontal cortex engagement during an fMRI task of emotion regulation as a potential predictor of treatment response in borderline personality disorder","volume":"364","author":"Michel","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111403_bb0435","article-title":"A comprehensive literature review of borderline personality disorder: unraveling complexity from diagnosis to treatment","volume":"15","author":"Mishra","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0440","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00406-023-01597-8","article-title":"Emotion dysregulation, impulsivity and anger rumination in borderline personality disorder: the role of amygdala and insula","volume":"274","author":"Mitolo","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0445","doi-asserted-by":"crossref","DOI":"10.47626\/2237-6089-2024-0788","article-title":"A hierarchical analysis of associated factors to lifetime suicide attempts in alcohol use disorder","author":"Mo\u00e7ambique","year":"2024","journal-title":"Trends Psychiatry Psychother."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0450","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jad.2020.05.007","volume":"274","author":"Molavi","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0455","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.comppsych.2018.03.007","article-title":"The relation of borderline personality disorder to aggression, victimization, and institutional misconduct among prisoners","volume":"84","author":"Moore","year":"2018","journal-title":"Compr. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0460","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2019.16","article-title":"Brain structure and symptom dimensions in borderline personality disorder","volume":"63","author":"Nenadi\u0107","year":"2020","journal-title":"Eur. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111403_bb0465","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neulet.2006.09.002","article-title":"Serotonin 2A receptor gene is associated with personality traits, but not to disorder, in patients with borderline personality disorder","volume":"408","author":"Ni","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111403_bb0470","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/10398562231153009","article-title":"Overdose and off-label psychotropic prescribing in patients with borderline personality disorder: a retrospective series","volume":"31","author":"Ning","year":"2023","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscychresns.2024.111808","article-title":"Amygdala functional connectivity in borderline personality disorder","volume":"340","author":"Noor","year":"2024","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0480","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3389\/fpsyg.2019.01694","article-title":"Metacognitive therapy of early traumatized patients with borderline personality disorder: a phase-II baseline-controlled trial","volume":"10","author":"Nordahl","year":"2019","journal-title":"Front. Psychol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0485","doi-asserted-by":"crossref","DOI":"10.1521\/pedi.2009.23.4.333","article-title":"Volumes of the hippocampus and amygdala in patients with borderline personality disorder: a meta-analysis","volume":"23","author":"Nunes","year":"2009","journal-title":"J. Personal. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0490","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40479-022-00178-w","article-title":"Cluster analysis of personality traits in psychiatric patients with borderline personality disorder","volume":"9","author":"Oladottir","year":"2022","journal-title":"Borderline Personal. Disord. Emot. Dysregul."},{"issue":"16","key":"10.1016\/j.pnpbp.2025.111403_bb0495","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jpsychires.2010.04.016","article-title":"Comorbidity of borderline personality disorder and posttraumatic stress disorder in the U.S. population","volume":"44","author":"Pagura","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0500","article-title":"Cariprazine in the management of emotionally unstable personality disorder in female patients: a case series","volume":"15","author":"Pappa","year":"2024","journal-title":"Front. Psychol."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0505","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/scan\/nsw016","article-title":"Alterations of amygdala-prefrontal connectivity with real-time fMRI neurofeedback in BPD patients","volume":"11","author":"Paret","year":"2016","journal-title":"Soc. Cogn. Affect. Neurosci."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111403_bb0510","first-page":"837","article-title":"Single-dose effects of citalopram on neural responses to affective stimuli in borderline personality disorder: a randomized clinical trial","volume":"6","author":"Paret","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0515","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.psc.2018.07.001","article-title":"Differential diagnosis of borderline personality disorder","volume":"41","author":"Paris","year":"2018","journal-title":"Psychiatr. Clin. N. Am."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0520","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/medicina55060223","article-title":"Suicidality in borderline personality disorder","volume":"55","author":"Paris","year":"2019","journal-title":"Medicina"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0525","series-title":"Treatment of Borderline Personality Disorder, Second Edition: a Guide to Evidence-Based Practice. Treatment of Borderline Personality Disorder","author":"Paris","year":"2020"},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111403_bb0530","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s40263-021-00852-7","article-title":"Twenty-year trends in the psychopharmacological treatment of outpatients with borderline personality disorder: a cross-sectional naturalistic study in Spain","volume":"35","author":"Pascual","year":"2021","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0535","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40263-023-01015-6","article-title":"Pharmacological management of borderline personality disorder and common comorbidities","volume":"37","author":"Pascual","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0540","first-page":"1","article-title":"Pharmacological interventions for co-occurring psychopathology in people with borderline personality disorder: secondary analysis of the Cochrane systematic review with meta-analyses","volume":"21","author":"Pereira Ribeiro","year":"2024","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0545","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/pcn.12357","article-title":"Frontolimbic neural circuit changes in emotional processing and inhibitory control associated with clinical improvement following transference-focused psychotherapy in borderline personality disorder","volume":"70","author":"Perez","year":"2016","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0550","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jad.2024.10.107","article-title":"Effect of metacognitive interpersonal therapy on brain structural connectivity in borderline personality disorder: results from the CLIMAMITHE randomized clinical trial","volume":"369","author":"Quattrini","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0555","series-title":"StatPearls","article-title":"Valproic acid","author":"Rahman","year":"2024"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111403_bb0560","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s40519-021-01320-3","article-title":"Evaluating the use of lamotrigine to reduce mood lability and impulsive behaviors in adults with chronic and severe eating disorders","volume":"27","author":"Reilly","year":"2022","journal-title":"Eat. Weight Disord."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111403_bb0565","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/15622975.2023.2186484","article-title":"Treatment of depression and borderline personality disorder with 1 Hz repetitive transcranial magnetic stimulation of the orbitofrontal cortex\u2013a pilot study","volume":"24","author":"Reinsberg","year":"2023","journal-title":"World J. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0570","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1590\/1516-4446-2016-2112","article-title":"Clinical improvement in patients with borderline personality disorder after treatment with repetitive transcranial magnetic stimulation: preliminary results","volume":"40","author":"Reyes-L\u00f3pez","year":"2018","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111403_bb0575","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/13651501.2019.1576904","article-title":"Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines","volume":"23","author":"Riffer","year":"2019","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111403_bb0580","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/jmft.12693","article-title":"Assessing family relations in borderline personality disorder: a relational approach","volume":"50","author":"Roca","year":"2024","journal-title":"J. Marital. Fam. Ther."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2025.111403_bb0585","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(03)00187-6","article-title":"Aberrant responses in social interaction of dopamine transporter knockout mice","volume":"148","author":"Rodriguiz","year":"2004","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111403_bb0590","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.biopsych.2010.03.013","article-title":"Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients","volume":"67","author":"Rosell","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0595","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1037\/per0000621","article-title":"Metacognitive interpersonal therapy in borderline personality disorder: clinical and neuroimaging outcomes from the CLIMAMITHE study\u2014a randomized clinical trial","volume":"14","author":"Rossi","year":"2023","journal-title":"Personal. Disord. Theory Res. Treat."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0600","article-title":"A randomised study and an extension study of brexpiprazole in patients with borderline personality disorder","volume":"37","author":"Rothman","year":"2024","journal-title":"Acta Neuropsych."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111403_bb0605","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biopsych.2012.07.014","article-title":"Neural correlates of negative emotionality in borderline personality disorder: an activation-likelihood-estimation meta-analysis","volume":"73","author":"Ruocco","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0610","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12888-022-04503-z","article-title":"The association between reattempted suicide and incoming calls to the brief contact intervention service, VigilanS: a study of the clinical profile of callers","volume":"23","author":"Rus\u00e9","year":"2023","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0615","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12888-019-2112-9","article-title":"Reduced mentalizing in patients with bulimia nervosa and features of borderline personality disorder: a case-control study","volume":"19","author":"Sacchetti","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0620","series-title":"StatPearls","article-title":"Electroconvulsive therapy","author":"Salik","year":"2025"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111403_bb0625","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/13811118.2020.1859031","article-title":"Hopelessness, interpersonal, and emotion dysregulation perspectives on suicidal ideation: tests in a clinical sample","volume":"26","author":"Schafer","year":"2022","journal-title":"Arch. Suicide Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0630","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1521\/pedi_2020_34_469","article-title":"Treatment for borderline personality disorder and secondary effects on somatization","volume":"35","author":"Schmaling","year":"2021","journal-title":"J. Personal. Disord."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0635","first-page":"548","article-title":"Effects of psychotherapy on neuronal correlates of reappraisal in female patients with borderline personality disorder","volume":"1","author":"Schmitt","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0640","doi-asserted-by":"crossref","first-page":"53","DOI":"10.9758\/cpn.2021.19.1.53","article-title":"Selective serotonin reuptake-inhibitors for symptom-based treatment of borderline personality disorders in older adults: an international delphi study","volume":"19","author":"Schulkens","year":"2021","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0645","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41598-018-37315-x","article-title":"Effects of transcranial direct current stimulation on the cognitive control of negative stimuli in borderline personality disorder","volume":"9","author":"Schulze","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0650","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1177\/1557988318792157","article-title":"Engaging men in psychological treatment: a scoping review","volume":"12","author":"Seidler","year":"2018","journal-title":"Am. J. Mens Health"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0655","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jad.2023.09.001","article-title":"Resting-state functional magnetic resonance imaging alterations in borderline personality disorder: a systematic review","volume":"341","author":"Shafie","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0660","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.psc.2018.07.009","article-title":"Comorbidity of borderline personality disorder: current status and future directions","volume":"41","author":"Shah","year":"2018","journal-title":"Psychiatr. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0665","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1037\/abn0000755","article-title":"Childhood trauma and borderline personality disorder traits: a discordant twin study","volume":"131","author":"Skaug","year":"2022","journal-title":"J. Psychopathol. Clin. Sci."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0670","article-title":"Recurrent mental health presentations to public hospital services: a focus on borderline personality disorder","volume":"26","author":"Smith","year":"2024","journal-title":"Prim. Care Compan. CNS Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0675","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40479-017-0066-4","article-title":"Subtypes of borderline personality disorder patients: a cluster-analytic approach","volume":"4","author":"Smits","year":"2017","journal-title":"Borderline Personal. Disord. Emot. Dysregul."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0680","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12888-020-02713-x","volume":"20","author":"Snoek","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0685","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/acps.13403","article-title":"\u201cSkills for pills\u201d: the dialectical-behavioural therapy skills training reduces polypharmacy in borderline personality disorder","volume":"145","author":"Soler","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111403_bb0690","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pscychresns.2014.03.008","article-title":"Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder","volume":"222","author":"Soloff","year":"2014","journal-title":"Psychiatry Res. Neuroimaging"},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111403_bb0695","article-title":"Psychological therapies for people with borderline personality disorder","volume":"2012","author":"Stoffers-Winterling","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111403_bb0700","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11920-020-01164-1","article-title":"Pharmacotherapy for borderline personality disorder: an update of published, unpublished and ongoing studies","volume":"22","author":"Stoffers-Winterling","year":"2020","journal-title":"Curr. Psychiatry Rep."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111403_bb0705","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41386-021-01163-7","article-title":"Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis","volume":"47","author":"Stogios","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0710","article-title":"Brain connectivity and symptom changes after transcranial magnetic stimulation in patients with borderline personality disorder","volume":"12","author":"Sverak","year":"2022","journal-title":"Front. Psychol."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0715","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2023.592","article-title":"Polypharmacy in the treatment of people diagnosed with borderline personality disorder: repeated cross-sectional study using New Zealand\u2019s national databases","volume":"9","author":"Tennant","year":"2023","journal-title":"BJPsych Open"},{"issue":"12","key":"10.1016\/j.pnpbp.2025.111403_bb0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084180","article-title":"Aberrant methylation of gene associated CpG sites occurs in borderline personality disorder","volume":"8","author":"Teschler","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0725","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12991-024-00507-z","article-title":"Treating depression in patients with borderline personality disorder: clinical clues on the use of antidepressants","volume":"23","author":"Tomasetti","year":"2024","journal-title":"Ann. General Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0730","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/comp.2000.16560","article-title":"A twin study of personality disorders","volume":"41","author":"Torgersen","year":"2000","journal-title":"Compr. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0735","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1521\/pedi.2007.21.6.603","article-title":"The role of affective instability and impulsivity in predicting future BPD features","volume":"21","author":"Tragesser","year":"2007","journal-title":"J. Personal. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0740","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s44220-022-00003-x","article-title":"A feasibility trial of conjoint magnetic seizure therapy and dialectical behavior therapy for suicidal patients with borderline personality disorder and treatment-resistant depression","volume":"1","author":"Traynor","year":"2023","journal-title":"Nat. Mental Health"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0745","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40479-018-0093-9","article-title":"Borderline personality disorder and substance use disorders: an updated review","volume":"5","author":"Trull","year":"2018","journal-title":"Borderline Personal. Disord. Emot. Dysregul."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2025.111403_bb0750","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drugalcdep.2011.08.014","article-title":"The impact of borderline personality disorder on residential substance abuse treatment dropout among men","volume":"121","author":"Tull","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0755","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/pmh.1513","article-title":"Is social function a good proxy measure of personality disorder?","volume":"15","author":"Tyrer","year":"2021","journal-title":"Personal. Ment. Health"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0760","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/papt.12194","article-title":"Is mentalization-based therapy effective in treating the symptoms of borderline personality disorder? A systematic review","volume":"92","author":"Vogt","year":"2019","journal-title":"Psychol. Psychother. Theory Res. Pract."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0765","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pnpbp.2018.01.009","article-title":"Resting-state functional connectivity of neurotransmitter producing sites in female patients with borderline personality disorder","volume":"83","author":"Wagner","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0770","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuroimage.2016.12.013","article-title":"ACC GABA levels are associated with functional activation and connectivity in the fronto-striatal network during interference inhibition in patients with borderline personality disorder","volume":"147","author":"Wang","year":"2017","journal-title":"NeuroImage"},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111403_bb0775","article-title":"Role of electroconvulsive therapy in major depressive disorder with borderline personality disorder: case report and literature review","volume":"10","author":"Wasiq","year":"2018","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0780","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/JCP.0000000000000152","article-title":"Acute movement disorders associated with the use of second-generation antipsychotics in borderline personality disorder","volume":"34","author":"Willems","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111403_bb0785","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/10253890.2018.1451837","article-title":"Reduced levels of the endocannabinoid arachidonylethanolamide (AEA) in hair in patients with borderline personality disorder\u2013a pilot study","volume":"21","author":"Wingenfeld","year":"2018","journal-title":"Stress"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111403_bb0790","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1037\/per0000624","article-title":"Subtypes of borderline personality disorder in a day-clinic setting\u2014clinical and therapeutic differences","volume":"14","author":"Wolf","year":"2023","journal-title":"Personal. Disord. Theory Res. Treat."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropsychologia.2021.107850","article-title":"Challenging control over emotions in borderline personality disorder - a tDCS study","volume":"156","author":"Wolkenstein","year":"2021","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0800","series-title":"Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural and Neurodevelopmental Disorders","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0805","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jad.2021.01.042","article-title":"Facial emotion perception in borderline personality disorder: differential neural activation to ambiguous and threatening expressions and links to impairments in self and interpersonal functioning","volume":"284","author":"Wrege","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111403_bb0810","doi-asserted-by":"crossref","DOI":"10.1080\/20008066.2022.2163768","article-title":"Altered cortical thickness and emotional dysregulation in adolescents with borderline personality disorder","volume":"14","author":"Xiao","year":"2023","journal-title":"Eur. J. Psychotraumatol."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0815","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jad.2023.04.055","article-title":"Alteration of surface morphology and core features in adolescents with borderline personality disorder","volume":"333","author":"Xiao","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0820","first-page":"42","article-title":"Treatment approaches for borderline personality disorder","volume":"2","author":"Yeomans","year":"2012","journal-title":"Psychiatr. Times"},{"key":"10.1016\/j.pnpbp.2025.111403_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115619","article-title":"Association of white matter microstructural alteration with non-suicidal self-injury behavior and visual working memory in adolescents with borderline personality disorder","volume":"331","author":"Yi","year":"2024","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2025.111403_bb0830","article-title":"Improved emotion regulation after neurofeedback: a single-arm trial in patients with borderline personality disorder","volume":"24","author":"Zaehringer","year":"2019","journal-title":"NeuroImage"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111403_bb0835","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1176\/appi.ajp.2009.09081130","article-title":"Time to attainment of recovery from borderline personality disorder and stability of recovery: a 10-year prospective follow-up study","volume":"167","author":"Zanarini","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111403_bb0840","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1601-183X.2007.00353.x","article-title":"5-HT1A receptor gene C -1019 G polymorphism and amygdala volume in borderline personality disorder","volume":"7","author":"Zetzsche","year":"2008","journal-title":"Genes Brain Behav."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111403_bb0845","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/YCT.0000000000000916","article-title":"Exploring the utility of Neurostimulation therapies in the treatment of borderline personality disorder","volume":"39","author":"Zou","year":"2023","journal-title":"J. ECT"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625001575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625001575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:27:24Z","timestamp":1762284444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625001575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":171,"alternative-id":["S0278584625001575"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111403","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding borderline personality disorder: Clinical features, neurobiological insights, and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111403"}}